171 related articles for article (PubMed ID: 33878399)
21. Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae.
Han P; Pu M; Li Y; Fan H; Tong Y
Virol Sin; 2023 Oct; 38(5):801-812. PubMed ID: 37419417
[TBL] [Abstract][Full Text] [Related]
22. Isolation and Characterization of Two
Domingo-Calap P; Beamud B; Mora-Quilis L; González-Candelas F; Sanjuán R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365770
[TBL] [Abstract][Full Text] [Related]
23. Isolation of Four Lytic Phages Infecting
Domingo-Calap P; Beamud B; Vienne J; González-Candelas F; Sanjuán R
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936552
[TBL] [Abstract][Full Text] [Related]
24. A Comparative Study of Outer Membrane Proteome between Paired Colistin-Susceptible and Extremely Colistin-Resistant Klebsiella pneumoniae Strains.
Jasim R; Baker MA; Zhu Y; Han M; Schneider-Futschik EK; Hussein M; Hoyer D; Li J; Velkov T
ACS Infect Dis; 2018 Dec; 4(12):1692-1704. PubMed ID: 30232886
[TBL] [Abstract][Full Text] [Related]
25. Isolation and Characterization of the First
Gorodnichev RB; Kornienko MA; Malakhova MV; Bespiatykh DA; Manuvera VA; Selezneva OV; Veselovsky VA; Bagrov DV; Zaychikova MV; Osnach VA; Shabalina AV; Goloshchapov OV; Bespyatykh JA; Dolgova AS; Shitikov EA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835449
[TBL] [Abstract][Full Text] [Related]
26. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
[TBL] [Abstract][Full Text] [Related]
27. Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics.
Janssen AB; Doorduijn DJ; Mills G; Rogers MRC; Bonten MJM; Rooijakkers SHM; Willems RJL; Bengoechea JA; van Schaik W
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139278
[TBL] [Abstract][Full Text] [Related]
28. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
[TBL] [Abstract][Full Text] [Related]
29. Genomic Insights into Two Colistin-Resistant
Yap PSX; Ahmad Kamar A; Chong CW; Ngoi ST; Teh CSJ
Microb Drug Resist; 2020 Mar; 26(3):190-203. PubMed ID: 31545116
[No Abstract] [Full Text] [Related]
30. Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia.
Eckstein S; Stender J; Mzoughi S; Vogele K; Kühn J; Friese D; Bugert C; Handrick S; Ferjani M; Wölfel R; Millard A; Ben Moussa M; Bugert JJ
BMC Microbiol; 2021 Jun; 21(1):186. PubMed ID: 34154528
[TBL] [Abstract][Full Text] [Related]
31. Proteomic Study of the Interactions between Phages and the Bacterial Host
Bleriot I; Blasco L; Pacios O; Fernández-García L; López M; Ortiz-Cartagena C; Barrio-Pujante A; Fernández-Cuenca F; Pascual Á; Martínez-Martínez L; Oteo-Iglesias J; Tomás M
Microbiol Spectr; 2023 Mar; 11(2):e0397422. PubMed ID: 36877024
[TBL] [Abstract][Full Text] [Related]
32. The evolutionary trade-offs in phage-resistant Klebsiella pneumoniae entail cross-phage sensitization and loss of multidrug resistance.
Majkowska-Skrobek G; Markwitz P; Sosnowska E; Lood C; Lavigne R; Drulis-Kawa Z
Environ Microbiol; 2021 Dec; 23(12):7723-7740. PubMed ID: 33754440
[TBL] [Abstract][Full Text] [Related]
33. Epitopes in the capsular polysaccharide and the porin OmpK36 receptors are required for bacteriophage infection of Klebsiella pneumoniae.
Dunstan RA; Bamert RS; Tan KS; Imbulgoda U; Barlow CK; Taiaroa G; Pickard DJ; Schittenhelm RB; Dougan G; Short FL; Lithgow T
Cell Rep; 2023 Jun; 42(6):112551. PubMed ID: 37224021
[TBL] [Abstract][Full Text] [Related]
34. Klebsiella virus UPM2146 lyses multiple drug-resistant Klebsiella pneumoniae in vitro and in vivo.
Assafiri O; Song AA; Tan GH; Hanish I; Hashim AM; Yusoff K
PLoS One; 2021; 16(1):e0245354. PubMed ID: 33418559
[TBL] [Abstract][Full Text] [Related]
35. Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae.
Park EA; Kim YT; Cho JH; Ryu S; Lee JH
Arch Virol; 2017 Apr; 162(4):1129-1139. PubMed ID: 28028618
[TBL] [Abstract][Full Text] [Related]
36. Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect.
Li M; Li P; Chen L; Guo G; Xiao Y; Chen L; Du H; Zhang W
Virus Genes; 2021 Oct; 57(5):434-442. PubMed ID: 34156584
[TBL] [Abstract][Full Text] [Related]
37. Exploitation of a
Nogueira CL; Pires DP; Monteiro R; Santos SB; Carvalho CM
ACS Infect Dis; 2021 Nov; 7(11):3077-3087. PubMed ID: 34618422
[No Abstract] [Full Text] [Related]
38. Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use.
Tu IF; Lin TL; Yang FL; Lee IM; Tu WL; Liao JH; Ko TP; Wu WJ; Jan JT; Ho MR; Chou CY; Wang AH; Wu CY; Wang JT; Huang KF; Wu SH
J Biomed Sci; 2022 Feb; 29(1):9. PubMed ID: 35130876
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.
Volozhantsev NV; Borzilov AI; Shpirt AM; Krasilnikova VM; Verevkin VV; Denisenko EA; Kombarova TI; Shashkov AS; Knirel YA; Dyatlov IA
Virus Res; 2022 Dec; 322():198951. PubMed ID: 36191686
[TBL] [Abstract][Full Text] [Related]
40. Phages for treatment of Klebsiella pneumoniae infections.
Zaki BM; Hussein AH; Hakim TA; Fayez MS; El-Shibiny A
Prog Mol Biol Transl Sci; 2023; 200():207-239. PubMed ID: 37739556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
